Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?
OMA1 cristae remodeling
OPA1
apoptosis
cardiomyocyte
ischemia-reperfusion injury
ischemic preconditioning
mitochondrial morphosis
remote ischemic conditioning
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
05
07
2022
revised:
23
09
2022
accepted:
26
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Disruption of mitochondrial structure/function is well-recognized to be a determinant of cell death in cardiomyocytes subjected to lethal episodes of ischemia-reperfusion (IR). However, the precise mitochondrial event(s) that precipitate lethal IR injury remain incompletely resolved. Using the in vitro HL-1 cardiomyocyte model, our aims were to establish whether: (1) proteolytic processing of optic atrophy protein-1 (OPA1), the inner mitochondrial membrane protein responsible for maintaining cristae junction integrity, plays a causal, mechanistic role in determining cardiomyocyte fate in cells subjected to lethal IR injury; and (2) preservation of OPA1 may contribute to the well-documented cardioprotection achieved with ischemic preconditioning (IPC) and remote ischemic conditioning. We report that HL-1 cells subjected to 2.5 h of simulated ischemia displayed increased activity of OMA1 (the metalloprotease responsible for proteolytic processing of OPA1) during the initial 45 min following reoxygenation. This was accompanied by processing of mitochondrial OPA1 (i.e., cleavage to yield short-OPA1 peptides) and release of short-OPA1 into the cytosol. However, siRNA-mediated knockdown of OPA1 content did not exacerbate lethal IR injury, and did not attenuate the cardioprotection seen with IPC and a remote preconditioning stimulus, achieved by transfer of 'reperfusate' medium (TRM-IPC) in this cell culture model. Taken together, our results do not support the concept that maintenance of OPA1 integrity plays a mechanistic role in determining cell fate in the HL-1 cardiomyocyte model of lethal IR injury, or that preservation of OPA1 underlies the cardioprotection seen with ischemic conditioning.
Identifiants
pubmed: 36231044
pii: cells11193083
doi: 10.3390/cells11193083
pmc: PMC9564372
pii:
doi:
Substances chimiques
RNA, Small Interfering
0
Metalloproteases
EC 3.4.-
GTP Phosphohydrolases
EC 3.6.1.-
OPA1 protein, human
EC 3.6.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Cell Biol. 2007 Aug 27;178(5):757-64
pubmed: 17709430
Basic Res Cardiol. 2018 Mar 9;113(3):16
pubmed: 29524006
Circ Res. 2015 Feb 13;116(4):674-99
pubmed: 25677517
Basic Res Cardiol. 2016 Sep;111(5):59
pubmed: 27573530
Life Sci. 2007 Sep 8;81(13):1042-9
pubmed: 17854840
Mol Vis. 2008;14:2629-38
pubmed: 19122832
Antioxid Redox Signal. 2013 Aug 1;19(4):400-14
pubmed: 22793879
Basic Res Cardiol. 2003 Jul;98(4):235-41
pubmed: 12835952
Appl Microbiol. 1966 Nov;14(6):985-8
pubmed: 16349706
Arch Biochem Biophys. 1993 Jun;303(2):474-82
pubmed: 8390225
Circulation. 2010 May 11;121(18):2012-22
pubmed: 20421521
Biochem J. 1990 Feb 15;266(1):33-9
pubmed: 2106875
N Engl J Med. 2015 Oct 8;373(15):1397-407
pubmed: 26436208
Cell. 2006 Jul 14;126(1):177-89
pubmed: 16839885
J Cell Biol. 2016 Feb 29;212(5):531-44
pubmed: 26903540
Circulation. 1986 Nov;74(5):1124-36
pubmed: 3769170
Nature. 2005 Mar 31;434(7033):652-8
pubmed: 15800626
Exp Clin Cardiol. 2003 Spring;8(1):5-9
pubmed: 19644579
J Am Heart Assoc. 2013 Oct 08;2(5):e000461
pubmed: 24103571
Mol Cell Neurosci. 2015 Jan;64:116-22
pubmed: 25579226
Shock. 2016 Feb;45(2):192-7
pubmed: 26555744
Ross Fiziol Zh Im I M Sechenova. 2010 Dec;96(12):1170-89
pubmed: 21473105
JACC Basic Transl Sci. 2016 Oct 31;1(6):524-535
pubmed: 30167535
Cardiovasc Res. 2010 Oct 1;88(1):16-29
pubmed: 20631158
Clin Sci (Lond). 2009 Aug 03;117(5):191-200
pubmed: 19175358
J Cell Biol. 2009 Dec 28;187(7):959-66
pubmed: 20038677
J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71
pubmed: 25857912
Mol Cell Neurosci. 2016 Oct;76:68-75
pubmed: 27567688
J Pharmacol Exp Ther. 2020 Jan;372(1):95-106
pubmed: 31704803
Science. 1965 Feb 26;147(3661):1033-4
pubmed: 17813309
Cardiovasc Res. 2002 Aug 15;55(3):534-43
pubmed: 12160950
Basic Res Cardiol. 2021 Sep 13;116(1):52
pubmed: 34515837
N Engl J Med. 2008 Jul 31;359(5):473-81
pubmed: 18669426
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
J Biol Chem. 2005 Oct 21;280(42):35742-50
pubmed: 16115883
Biochem J. 1995 Apr 1;307 ( Pt 1):93-8
pubmed: 7717999
PLoS One. 2012;7(7):e37948
pubmed: 22815687
Eur Heart J. 2016 Jan 7;37(2):200-2
pubmed: 26508160
Circulation. 1993 Mar;87(3):893-9
pubmed: 7680290
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14782-7
pubmed: 25275009
Thromb Haemost. 2015 Mar;113(3):513-21
pubmed: 25253080
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1318-26
pubmed: 24671334
N Engl J Med. 2015 Oct 8;373(15):1408-17
pubmed: 26436207
J Am Coll Cardiol. 2006 Mar 21;47(6):1236; author reply 1236-7
pubmed: 16545664
Curr Protoc Immunol. 2015 Nov 02;111:A3.B.1-A3.B.3
pubmed: 26529666
Annu Rev Physiol. 2016;78:505-31
pubmed: 26667075
J Immunol Methods. 1986 Nov 20;94(1-2):57-63
pubmed: 3782817
Cell Metab. 2014 Apr 1;19(4):630-41
pubmed: 24703695
Biochem Soc Trans. 2006 Apr;34(Pt 2):232-7
pubmed: 16545083
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
pubmed: 9501201
J Cell Sci. 2019 Jan 25;132(2):
pubmed: 30518622
Basic Res Cardiol. 2013 Nov;108(6):392
pubmed: 24158692
Exp Cell Res. 2009 Aug 1;315(13):2165-80
pubmed: 19409380
Cardiovasc Res. 2009 Oct 1;84(1):91-9
pubmed: 19493956
PLoS One. 2016 Oct 10;11(10):e0164066
pubmed: 27723783
J Am Heart Assoc. 2012 Oct;1(5):e003012
pubmed: 23316298
Mitochondrion. 2019 May;46:1-5
pubmed: 30926535
J Mol Cell Cardiol. 1997 Apr;29(4):1255-66
pubmed: 9160877
Biochem J. 1988 Oct 1;255(1):357-60
pubmed: 3196322
Nat Protoc. 2007;2(2):287-95
pubmed: 17406588
Cell Physiol Biochem. 2020 Oct 30;54(6):1101-1114
pubmed: 33119220
EMBO J. 2005 Apr 20;24(8):1546-56
pubmed: 15791210
Cardiovasc Res. 2019 Dec 1;115(14):e161-e163
pubmed: 31621833
Science. 2015 Dec 4;350(6265):aad0116
pubmed: 26785494
Lancet. 2019 Oct 19;394(10207):1415-1424
pubmed: 31500849
Cell Metab. 2015 Jun 2;21(6):834-44
pubmed: 26039448
Int J Mol Sci. 2019 Aug 15;20(16):
pubmed: 31443187
Sci Rep. 2016 Aug 04;6:30922
pubmed: 27488808
J Am Coll Cardiol. 2016 Feb 2;67(4):375-378
pubmed: 26821624
N Engl J Med. 2013 Dec 5;369(23):2236-51
pubmed: 24304053
EMBO Rep. 2014 May;15(5):576-85
pubmed: 24719224
N Engl J Med. 2015 Sep 10;373(11):1021-31
pubmed: 26321103
Cell Mol Life Sci. 2017 Apr;74(7):1347-1363
pubmed: 27858084
Sci Rep. 2015 Sep 14;5:13989
pubmed: 26365306
J Biol Chem. 2006 Oct 6;281(40):29776-87
pubmed: 16882669